The pharmaceutical industry develops, manufactures, and sells drugs. Defining illness is not its mission. Generally, the medications produced by drug companies target diseases that have been defined previously by the medical profession. However, there are several indirect ways in which the industry contributes to the definition of illness. Are these contributions beneficial to society and ethically sound, or are they solely aimed at maximizing corporate profit? To address these questions, I analyze some examples of how the pharmaceutical industry has played a role in defining illness.
No takes yet. Share an insight, caveat, or question.
Elizabeth A. Kitsis (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: